Investors celebrated the company's progress yesterday. But they quickly turned on the stock today after seeing lackluster Q2 results.

At $13.6 billion in market capitalization, Hims & Hers stock costs a pricey 70 times trailing earnings. It's even more expensive when valued on FCF -- about 103 times. These might be acceptable ...

The headliner was the U.S. commercial segment, as new customers continued to flock to Palantir's Artificial Intelligence ...

The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy. Neil is ...

The fervor peaked on July 21 when the stock crashed after trading was halted and some investors mistook a company called Open ...

Backlog -- Backlog reached a record of nearly $23 billion in Q3 fiscal 2025, up 14% year-over-year; Trailing twelve-month ...

The midyear 2025 reserve report used a lower average SEC twelve-month crude oil price ($71.22 per barrel) compared to the ...

Whether you're looking for growth stocks, dividend stocks, or artificial intelligence stocks, there is something for you in this incredible list.

AMD had a terrific month of July, and it didn't even post earnings yet. That comes today, after a slew of good news.

Lemonade stock was sagging last month as home sales are still disappointing, and home insurance is its core product.

The company assessed goodwill for impairment and recorded a $77 million noncash impairment charge in the pain management and ...

The decade before you retire is the right time to figure out which parts of your retirement plan shine and which need a ...